Abstract
Aim: Nonalcoholic fatty liver disease (NAFLD) is associated with inflammation and increased risk of atherosclerosis. Neopterin is regarded as a biochemical marker of cell-mediated immunity, which is secreted by monocytes and macrophages, mainly in response to interferon-gamma. The aim of the present study was to investigate the serum neopterin levels in obese adolescents and compare the neopterin levels in patients with and without NAFLD and also with healthy controls. The second aim of the study was to research the possible relationship between neopterin levels and adipokines (leptin, adiponectin, resistin, and ghrelin).
Methods: Ninety-three obese adolescents (39 with NAFLD, 54 without NAFLD) and 55 healthy controls were enrolled in the study. Serum levels of neopterin and adipokines were measured with high-performance liquid chromatography and sandwich enzyme-linked immunosorbent assay, respectively.
Results: Serum neopterin levels were significantly higher in patients with NAFLD (3.20±0.09 nmol/L) than in their healthy peers (2.91±0.08 nmol/L) (p=0.020). Neopterin levels were positively correlated with leptin levels in obese patients (r=0.380, p<0.001) and in the group comprising all individuals (r=0.206, p<0.05). There was no correlation between neopterin concentrations and relative weight, alanin aminotransferase, adiponectin, resistin, and ghrelin levels.
Conclusion: The serum neopterin levels were significantly higher in obese adolescents with fatty liver disease compared to controls, and this may be related to increased cell-mediated immunity in fatty liver disease.
Conflict of interest statement
Authors’ conflict of interest disclosure: None declared.
Support: This study was supported by The Scientific & Technological Research Council of Turkey (TUBITAK) (project number: SBAG 111S016).
References
1. Sinatra FR. Nonalcoholic fatty liver disease in pediatric patients. J Parenter Enteral Nutr 2012;36:43S–8S.10.1177/0148607111421610Search in Google Scholar PubMed
2. Arslan N, Büyükgebiz B, Oztürk Y, Cakmakci H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005;47:23–7.Search in Google Scholar
3. Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012;9:152–61.10.1038/nrgastro.2011.273Search in Google Scholar PubMed
4. Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, et al. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008;53:1352–7.10.1007/s10620-007-9998-7Search in Google Scholar PubMed
5. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 2009;204:521–5.10.1016/j.atherosclerosis.2008.09.012Search in Google Scholar PubMed
6. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008;63:423–7.10.1203/PDR.0b013e318165b8e7Search in Google Scholar PubMed
7. Demircioğlu F, Koçyiğit A, Arslan N, Cakmakçi H, Hizli S, et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008;47:68–75.10.1097/MPG.0b013e31816232c9Search in Google Scholar PubMed
8. Arslan N, Makay B. Mean platelet volume in obese adolescents with nonalcoholic fatty liver disease. J Pediatr Endocrinol Metab 2010;23:807–13.10.1515/jpem.2010.130Search in Google Scholar PubMed
9. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169–80.10.1053/j.gastro.2007.03.059Search in Google Scholar PubMed
10. Homann C, Benfield TL, Graudal NA, Garred P. Neopterin and interleukin-8-prognosis in alcohol-induced cirrhosis. Liver 2000;20:442–9.10.1034/j.1600-0676.2000.020006442.xSearch in Google Scholar PubMed
11. Wilmer A, Nölchen B, Tilg H, Herold M, Pechlaner C, et al. Serum neopterin concentrations in chronic liver disease. Gut 1995;37:108–12.10.1136/gut.37.1.108Search in Google Scholar PubMed PubMed Central
12. Kalkan A, Ozden M, Akbulut H. Serum neopterin levels in patients with chronic hepatitis B. Jpn J Infect Dis 2005;58:107–9.Search in Google Scholar
13. Demirturk N, Demirdal T, Aktepe OC, Aykin N, Orhan S, et al. Serum neopterin levels in patients with HBV infection at various stages. Hepatogastroenterology 2007;54:903–5.Search in Google Scholar
14. Gulcan EM, Tirit I, Anil A, Adal E, Ozbay G. Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity. World J Gastroenterol 2008;14:6840–3.10.3748/wjg.14.6840Search in Google Scholar
15. Kilic D, Boyunağa H, Kaygusuz S, Akgül E, Al Rashed M, et al. Neopterin levels in nonreplicative HBV carriers. Hepatol Res 2002;24:18.10.1016/S1386-6346(02)00012-8Search in Google Scholar
16. Schaefer CJ, Kossen K, Lim SR, Lin JH, Pan L, et al. Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother 2011;55:3125–32.10.1128/AAC.00131-11Search in Google Scholar
17. Demirbas S, Cakir E, Akgul EO, Seyrek M, Cayci T, et al. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environ Toxicol Pharmacol 2011;31:165–70.10.1016/j.etap.2010.10.003Search in Google Scholar
18. Strauss RS. Childhood obesity. Pediatr Clin North Am 2002;49:175–201.10.1016/S0031-3955(03)00114-7Search in Google Scholar
19. Quin SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. Am J Roentgenol 1985;145:753–5.10.2214/ajr.145.4.753Search in Google Scholar PubMed
20. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649–58.10.1542/peds.98.4.649Search in Google Scholar
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–9.10.1007/BF00280883Search in Google Scholar PubMed
22. Flavall EA, Crone EM, Moore GA, Gieseg SP. Dissociation of neopterin and 7,8-dihydroneopterin from plasma components before HPLC analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2008;863:167–71.10.1016/j.jchromb.2007.12.019Search in Google Scholar PubMed
23. Carru C, Zinellu A, Sotgia A, Serra R, Usai MF, et al. A new HPLC method for serum neopterin measurement and relationships with plasma thiols levels in healthy subjects. Biomed Chromatogr 2004;18:360–6.10.1002/bmc.325Search in Google Scholar PubMed
24. Ledochowski M, Murr C, Widner B, Fuchs D. Association between insulin resistance, body mass and neopterin concentrations. Clin Chim Acta 1999;282:115–23.10.1016/S0009-8981(99)00019-4Search in Google Scholar
25. Ursavaş A, Karadag M, Oral AY, Demirdogen E, Oral HB, et al. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med 2008;102:1193–7.10.1016/j.rmed.2008.02.019Search in Google Scholar PubMed
26. Spencer ME, Jain A, Matteini A, Beamer BA, Wang NY, et al. Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci 2010;65:858–65.10.1093/gerona/glq066Search in Google Scholar PubMed PubMed Central
27. Bozdemir AE, Barutcuoglu B, Dereli D, Kabaroglu C, Habif S, et al. C-reactive protein and neopterin levels in healthy non-obese adults. Clin Chem Lab Med 2006;44:317–21.10.1515/CCLM.2006.055Search in Google Scholar PubMed
28. Oxenkrug G, Tucker KL, Requintina P, Summergrad P. Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5′-phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston community dwellers of Puerto Rican origin. Am J Neuroprot Neuroregen 2011;3:48–52.10.1166/ajnn.2011.1024Search in Google Scholar PubMed PubMed Central
29. Rao VS, Nagaraj RK, Hebbagodi S, Kadarinarasimhiah NB, Kakkar VV. Association of inflammatory and oxidative stress markers with metabolic syndrome in Asian Indians in India. Cardiol Res Pract 2010;2011:295976.Search in Google Scholar
30. Mangge H, Freytag F, Almer G, Weghuber D, Bauer-Denk C, et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795. doi: 10.1155/2011/946795. Epub 2011 Jan 12.10.1155/2011/946795Search in Google Scholar PubMed PubMed Central
31. Kabaroğlu C, Onur E, Barutçuoğlu B, Özhan B, Erdinç S, et al. Inflammatory marker levels in obese adolescents with glucose intolerance: increased chitotriosidase activity. Clin Biochem 2012;45:281–4.10.1016/j.clinbiochem.2011.12.007Search in Google Scholar PubMed
32. Canas JA, Damaso L, Altomare A, Killen K, Hossain J, et al. Insulin resistance and adiposity in relation to serum β-carotene levels. J Pediatr 2012;161:58–64.10.1016/j.jpeds.2012.01.030Search in Google Scholar PubMed
33. Kelly AS, Metzig AM, Schwarzenberg SJ, Norris AL, Fox CK, et al. Hyperleptinemia and hypoadiponectinemia in extreme pediatric obesity. Metab Syndr Relat Disord 2012;10:123–7.10.1089/met.2011.0086Search in Google Scholar PubMed PubMed Central
34. Pedrosa C, Oliveira BM, Albuquerque I, Simões-Pereira C, Vaz-de-Almeida MD, et al. Obesity and metabolic syndrome in 7–9 years-old Portuguese schoolchildren. Diabetol Metab Syndr 2010;2:40.10.1186/1758-5996-2-40Search in Google Scholar PubMed PubMed Central
35. Uygun A, Kadayifci A, Musabak U, Ercin N, Karslioglu Y, et al. Serum neopterin levels in patients with non-alcoholic steatohepatitis. Hepatol Res 2008;38:904–8.10.1111/j.1872-034X.2008.00348.xSearch in Google Scholar PubMed
36. Yaman H, Cakır E, Ozcan O, Yesilova Z, Ozcan A, et al. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem 2005;38:187–90.10.1016/j.clinbiochem.2004.10.008Search in Google Scholar PubMed
37. Abdou AS, Magour GM, Mahmoud MM. Evaluation of some markers of subclinical atherosclerosis in Egyptian young adult males with abdominal obesity. Br J Biomed Sci 2009;66: 143–7.10.1080/09674845.2009.11730261Search in Google Scholar PubMed
38. Johnston, DT, Gagos M, Raio N, Ragolia L, Shenouda D, et al. Alterations in serum neopterin correlate with thrombolysis in myocardial infarction risk scores in acute coronary syndromes. Coron Artery Dis 2006;17:511–6.10.1097/00019501-200609000-00003Search in Google Scholar PubMed
39. Ray KK, Morrow DA, Sabatine S, Shui A, Rifai N, et al. Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007;115:3071–8.10.1161/CIRCULATIONAHA.106.666511Search in Google Scholar PubMed
40. Adachi T, Naruko T, Itoh A, Komatsu R, Abe Y, et al. Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 2007;93:1537–41.10.1136/hrt.2006.109736Search in Google Scholar PubMed PubMed Central
41. Kashi JC, Consuegra-Sanchez L, Fernandez-Berges DJ, Cruz-Fernandez JM, Garcia-Moll X, et al.; SIESTA Investigators. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis 2008;201:176–83.10.1016/j.atherosclerosis.2008.01.009Search in Google Scholar PubMed
42. Alber HF, Duftner M, Wanitschek M, Dörler J, Schirmer M, et al. Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol 2009;135:27–35.10.1016/j.ijcard.2008.03.010Search in Google Scholar PubMed
43. Videm V, Wiseth R, Gunnes S, Madsen HO, Garred P. Multiple inflammatory markers in patients with significant coronary artery disease. Int J Cardiol 2007;118:81–7.10.1016/j.ijcard.2006.07.005Search in Google Scholar PubMed
44. Grammer TB, Fuchs D, Boehm BO, Winkelmann BR, Maerz W. Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 2009;55:1135–46.10.1373/clinchem.2008.118844Search in Google Scholar PubMed
45. Vengen IT, Dale AC, Wiseth R, Midthjell K, Videm V. Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus. Long-term follow-up of the HUNT 1 study. Atherosclerosis 2009;207:239–44.10.1016/j.atherosclerosis.2009.04.003Search in Google Scholar
46. Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC. Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005;26:457–63.10.1093/eurheartj/ehi111Search in Google Scholar
47. Auer J, Berent R, Labnig E, Eber B. Serum neopterin and activity of coronary artery disease. Heart Dis 2001;3:297–301.10.1097/00132580-200109000-00004Search in Google Scholar
48. Hoffmann G, Schobersberger W, Frede S, Pelzer L, Fandrey J, et al. Neopterin activates transcription factor nuclear factor-κB in vascular smooth muscle cells. FEBS Lett 1996;391: 181–4.10.1016/0014-5793(96)00729-6Search in Google Scholar
49. Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra-Sanchez L, et al. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 2009;16: 4644–53.10.2174/092986709789878247Search in Google Scholar
50. Hoffmann G, Kenn S, Wirleitner B, Deetjen C, Frede S, et al. Neopterin induces nitric oxide-dependent apoptosis in rat vascular smooth muscle cells. Immunobiology 1998;199: 63–73.10.1016/S0171-2985(98)80064-8Search in Google Scholar
©2013 by Walter de Gruyter Berlin Boston
